<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type='text/xml' href='//inventivapharma.com/?wds_sitemap_styling=1&#038;template=sitemapBody'?><!-- SMARTCRAWL SITEMAP -->
<urlset
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	>
			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-FY-2018-27-02-19-EN-1.pdf</loc>
<lastmod>2018-02-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Amendment-to-the-Call-Option-Agreement-22-08-18.pdf</loc>
<lastmod>2018-07-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-RP-JPM-Healthcare-Conference-FR-10.12.18.pdf</loc>
<lastmod>2018-12-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-RP-JPM-Healthcare-Conference-FR-10.12.18.pdf</loc>
<lastmod>2018-12-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Abstract-Acceptance-at-the-ILC-04-02-19-EN.pdf</loc>
<lastmod>2019-02-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Acceptance-dAbstract-au-ILC-04-02-19-FR.pdf</loc>
<lastmod>2019-02-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FASST-results-EN-18-02-19.pdf</loc>
<lastmod>2019-02-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-FASST-results-FR-18-02-19.pdf</loc>
<lastmod>2019-02-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATIVE-update-FR-21-02-19.pdf</loc>
<lastmod>2019-02-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-FASST-results-FR-18-02-19.pdf</loc>
<lastmod>2019-02-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cowen-Company-Health-Care-Conferenc-EN-06-03-19-2.pdf</loc>
<lastmod>2019-03-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Cowen-Company-Health-Care-Conference-FR-06-03-19-1.pdf</loc>
<lastmod>2019-03-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H.C-Wainwright-Global-Life-Sciences-Conference-03-04-2019.pdf</loc>
<lastmod>2019-04-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H.C-Wainwright-Global-Life-Sciences-Conference-03-04-2019.pdf</loc>
<lastmod>2019-04-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AACR-Special-Conference-on-Hippo-Pathway-23-04-19-EN.pdf</loc>
<lastmod>2019-04-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AACR-Special-Conference-on-Hippo-Pathway-23-04-19-FR.pdf</loc>
<lastmod>2019-04-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lifting-of-clinical-hold-EN-23-05-19.pdf</loc>
<lastmod>2019-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lifting-of-clinical-hold-FR-23-05-19.pdf</loc>
<lastmod>2019-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-Healthcare-Conference-2019-EN-24-05-19.pdf</loc>
<lastmod>2019-05-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-Healthcare-Conference-2019-FR-24-05-19.pdf</loc>
<lastmod>2019-05-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Board-of-directors-EN-29-05-2019-VF.pdf</loc>
<lastmod>2019-05-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Board-of-Directors-FR-29-05-19-VF.pdf</loc>
<lastmod>2019-05-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-End-of-recruitement-iMProveS-EN-11-06-19.pdf</loc>
<lastmod>2019-06-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Fin-du-recrutement-iMProveS-FR-11-06-19.pdf</loc>
<lastmod>2019-06-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-SAB-EN-13-06-19.pdf</loc>
<lastmod>2019-06-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Nouveau-brevet-US-FR-20-08-19.pdf</loc>
<lastmod>2019-06-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-CA-Cash-H1-2019-EN-30-07-19-1.pdf</loc>
<lastmod>2019-07-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-New-patent-US-EN-20-08-19.pdf</loc>
<lastmod>2019-08-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ASSLD-The-Liver-Meeting-EN-26-08-19.pdf</loc>
<lastmod>2019-08-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ASSLD-The-Liver-Meeting-FR-26-08-19.pdf</loc>
<lastmod>2019-08-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-New-patent-Europe-EN-28082019.pdf</loc>
<lastmod>2019-08-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Nouveau-brevet-Europe-FR-28082019.pdf</loc>
<lastmod>2019-08-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Follow-up-biomarker-02-09-19-EN-VF.pdf</loc>
<lastmod>2019-09-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Follow-up-biomarker-02-09-19-FR-VF.pdf</loc>
<lastmod>2019-09-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATIVE-End-of-recruitment-EN-04-09-2019.pdf</loc>
<lastmod>2019-09-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NATIVE-End-of-recruitment-FR-04-09-2019.pdf</loc>
<lastmod>2019-09-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-4eme-DSMB-EN-10-09-19-VF.pdf</loc>
<lastmod>2019-09-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-4eme-DSMB-FR-10-09-19-VF.pdf</loc>
<lastmod>2019-09-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_CP_Leve-de-fonds-EN_09192019_clean.pdf</loc>
<lastmod>2019-09-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Levee-de-fonds-FR_09192019_clean.pdf</loc>
<lastmod>2019-09-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2019-EN-25-09-19.pdf</loc>
<lastmod>2019-09-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-S1-2019-FR-25-09-19.pdf</loc>
<lastmod>2019-09-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-FDA-Fast-Track-EN-26092019-VF.pdf</loc>
<lastmod>2019-09-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-FDA-Fast-Track-FR-26092019-VF.pdf</loc>
<lastmod>2019-09-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_PR_Sofinnova_30092019.pdf</loc>
<lastmod>2019-09-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Sofinnova_30092019.pdf</loc>
<lastmod>2019-09-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-HC-Wainwright-Gilbert-Dupont-EN-15-10-19.pdf</loc>
<lastmod>2019-10-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-HC-Wainwright-Gilbert-Dupont-FR-15-10-19.pdf</loc>
<lastmod>2019-10-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-London-Healthcare-Conference-2019-EN-VF.pdf</loc>
<lastmod>2019-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Jefferies-London-Healthcare-Conference-2019-FR-VF.pdf</loc>
<lastmod>2019-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2019-EN-13112019-VF-1.pdf</loc>
<lastmod>2019-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2019-FR-13112019-VF-1.pdf</loc>
<lastmod>2019-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ABBV157-EN-03-12-19-VF.pdf</loc>
<lastmod>2019-12-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ABBV157-FR-03-12-19-VF.pdf</loc>
<lastmod>2019-12-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-iMProveS-results-EN-18-12-19-VF.pdf</loc>
<lastmod>2019-12-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-iMProveS-results-FR-18-12-19-VF.pdf</loc>
<lastmod>2019-12-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-SRD-long-only-20-12-19-VF.pdf</loc>
<lastmod>2020-01-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-SRD-long-only-06-01-20-VF.pdf</loc>
<lastmod>2020-01-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Annual-World-Symposium-03-02-2020-EN-VF.pdf</loc>
<lastmod>2020-02-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Annual-World-Symposium-03-02-2020-FR-VF.pdf</loc>
<lastmod>2020-02-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cash-and-Revenues-FY-2019-05-02-20-EN-VF-1.pdf</loc>
<lastmod>2020-02-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Cash-et-CA-FY-2019-05-02-20-FR-VF-1.pdf</loc>
<lastmod>2020-02-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_PR_Capital-increase_07022020.pdf</loc>
<lastmod>2020-02-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Augmentation-de-capital_07022020.pdf</loc>
<lastmod>2020-02-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-mise-a-dispo-EN_v.-finale.pdf</loc>
<lastmod>2020-02-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-mise-a-dispo-FR_v.-finale.pdf</loc>
<lastmod>2020-02-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2019-10-03-20-VF-EN-1.pdf</loc>
<lastmod>2020-03-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Last-Patient-Last-Visit-170320-VF-EN-clean.pdf</loc>
<lastmod>2020-03-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Last-Patient-Last-Visit-170320-VF-FR-clean.pdf</loc>
<lastmod>2020-03-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-COVID-19-07-04-2020-EN-VF.pdf</loc>
<lastmod>2020-04-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-COVID-19-07-04-2020-FR-VF.pdf</loc>
<lastmod>2020-04-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-MAD-RFA-09-04-20.pdf</loc>
<lastmod>2020-04-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATIVE-KOL-EN-21-04-20-VF.pdf</loc>
<lastmod>2020-04-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NATIVE-KOL-FR-21-04-20-VF.pdf</loc>
<lastmod>2020-04-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-06052020_VDEF-1.pdf</loc>
<lastmod>2020-05-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-06052020_VDEF-1.pdf</loc>
<lastmod>2020-05-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2020-EN-14052020-1.pdf</loc>
<lastmod>2020-05-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2020-FR-14052020-1.pdf</loc>
<lastmod>2020-05-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Odiparcil-PLOS-ONE-EN-18-05-2020-VF.pdf</loc>
<lastmod>2020-05-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Odiparcil-PLOS-ONE-FR-18-05-2020-VF.pdf</loc>
<lastmod>2020-05-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-PGE-19-05-2020-EN.pdf</loc>
<lastmod>2020-05-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-PGE-19-05-2020-FR.pdf</loc>
<lastmod>2020-05-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-New-patent-China-EN-22052020-VF.pdf</loc>
<lastmod>2020-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Nouveau-brevet-Chine-FR-25052020-VF.pdf</loc>
<lastmod>2020-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-Virtual-Healthcare-Conference-2020-EN-02-06-20.pdf</loc>
<lastmod>2020-06-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Jefferies-Virtual-Healthcare-Conference-2020-FR-02-06-20.pdf</loc>
<lastmod>2020-06-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATIVE-top-line-results-EN-15062020.pdf</loc>
<lastmod>2020-06-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NATIVE-top-line-results-FR-150620-VF.pdf</loc>
<lastmod>2020-06-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_PR_Public_Filing_190620.pdf</loc>
<lastmod>2020-06-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NAFLD-trial-patient-estimate-reduction-FR-05072020-Final.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NAFLD-trial-patient-estimate-reduction-EN-05072020-Final-1.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-Cash-2020-FR-06072020-1.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-Cash-2020-FR-06072020-1.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_PR_Launch_06072020.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Lancement-roadshow_06072020.pdf</loc>
<lastmod>2020-07-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Launch-and-price-range-EN-08.07.2020-final.pdf</loc>
<lastmod>2020-07-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Launch-and-price-range-FR-08.07.2020-final.pdf</loc>
<lastmod>2020-07-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Pricing-FV_10072020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Pricing-VF_10072020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Trading-Halt-EN-11-13-2025.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Trading-Halt-FR-VF.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_PR_Trading_Resumption_EN_07102020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Trading_Resumption_FR_07102020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva_CP-_Mise_a_dispo_FR_07102020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP-_Mise_a_dispo_FR_07102020.pdf</loc>
<lastmod>2020-07-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Closing-EN-15.07.2020.pdf</loc>
<lastmod>2020-07-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva_CP_Closing_FR_15072020.pdf</loc>
<lastmod>2020-07-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-September-events-EN-09-09-2020.pdf</loc>
<lastmod>2020-09-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-septembre-FR-09-09-2020.pdf</loc>
<lastmod>2020-09-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2020-EN-16-09-2020-1.pdf</loc>
<lastmod>2020-09-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2020-FR-16-09-2020-1.pdf</loc>
<lastmod>2020-09-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-October-events-EN-24-09-2020.pdf</loc>
<lastmod>2020-09-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-octobre-FR-24-09-2020.pdf</loc>
<lastmod>2020-09-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Plenary-EN-05-10-20.pdf</loc>
<lastmod>2020-10-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-Plenary-FR-05-10-20.pdf</loc>
<lastmod>2020-10-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-Breakthrough-Therapy-Designation-EN-12-10-20.pdf</loc>
<lastmod>2020-10-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Breakthrough-Therapy-Designation-FR-12-10-20.pdf</loc>
<lastmod>2020-10-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Odiparcil-FDA-Fast-Track-FR-19102020.pdf</loc>
<lastmod>2020-10-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Odiparcil-FDA-Fast-Track-EN-19102020.pdf</loc>
<lastmod>2020-10-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-KOL-EN-28-10-2020.pdf</loc>
<lastmod>2020-10-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-KOL-FR-28-10-2020.pdf</loc>
<lastmod>2020-10-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstract-EN-30-10-2020.pdf</loc>
<lastmod>2020-11-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-Abstract-FR-30-10-2020.pdf</loc>
<lastmod>2020-11-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NASH-Nature-Review-EN-02-11-20.pdf</loc>
<lastmod>2020-11-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NASH-Nature-Review-FR-02-11-20.pdf</loc>
<lastmod>2020-11-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Appointment-CMO-EN-05112020.pdf</loc>
<lastmod>2020-11-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Appointment-CMO-FR-05112020.pdf</loc>
<lastmod>2020-11-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-Stifel-Virtual-Healthcare-Conferences-EN-09-11-20.pdf</loc>
<lastmod>2020-11-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Jefferies-Stifel-Virtual-Healthcare-Conferences-FR-09-11-20.pdf</loc>
<lastmod>2020-11-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EOP2-Meeting-EN-10-11-2020-1.pdf</loc>
<lastmod>2020-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EOP2-Meeting-FR-10-11-2020-1.pdf</loc>
<lastmod>2020-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2020-EN-12-11-20-1.pdf</loc>
<lastmod>2020-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2020-FR-12-11-20-1.pdf</loc>
<lastmod>2020-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-CP-Piper-Sandler-32nd-Annual-Virtual-Healthcare-Conference-FR-24-11-20.pdf</loc>
<lastmod>2020-11-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Piper-Sandler-32nd-Annual-Virtual-Healthcare-Conference-FR-24-11-20.pdf</loc>
<lastmod>2020-11-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-Journal-of-Hepatology-EN-07-12-20.pdf</loc>
<lastmod>2020-12-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Journal-of-Hepatology-FR-07-12-20.pdf</loc>
<lastmod>2020-12-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-P3-Design-EN-050121-VF.pdf</loc>
<lastmod>2021-01-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-P3-Design-FR-050121-VF2-2.pdf</loc>
<lastmod>2021-01-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Annual-J.P.-Morgan-Healthcare-Conference-EN-06-01-2021.pdf</loc>
<lastmod>2021-01-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Annual-J.P.-Morgan-Healthcare-Conference-FR-06-01-2021.pdf</loc>
<lastmod>2021-01-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2020-23-02-2021-EN.pdf</loc>
<lastmod>2021-01-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Webcast-invitation-FY-2020-23-02-2021-FR.pdf</loc>
<lastmod>2021-01-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/PR-FY-2020-CA-Cash-EN-11022021-VF-1.pdf</loc>
<lastmod>2021-02-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/CP-FY-2020-CA-Cash-FR-11022021-VF-1.pdf</loc>
<lastmod>2021-02-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-March-events-23-02-2021-EN.pdf</loc>
<lastmod>2021-02-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-mars-23-02-2021-FR.pdf</loc>
<lastmod>2021-02-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-biomarker-25-02-2021-EN.pdf</loc>
<lastmod>2021-02-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-biomarker-25-02-2021-FR.pdf</loc>
<lastmod>2021-02-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2020-04-03-2021-EN-VF.pdf</loc>
<lastmod>2021-03-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-FY-2020-04-03-2021-FR-VF-1.pdf</loc>
<lastmod>2021-03-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/INVENTIVA-URD-and-20-F-PR-12-03-2021.pdf</loc>
<lastmod>2021-03-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-URD-et-20F-CP-12-03-2021.pdf</loc>
<lastmod>2021-03-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-Availability-of-the-preparatory-documents-25-03-2021-1.pdf</loc>
<lastmod>2021-03-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-Mise-a-disposition-des-documents-25-03-2021.pdf</loc>
<lastmod>2021-03-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Appointment-Martine-Zimmermann-19-04-2021-EN-VF.pdf</loc>
<lastmod>2021-04-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Appointment-Martine-Zimmermann-19-04-2021-FR-VF.pdf</loc>
<lastmod>2021-04-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-7th-Annual-Truist-Securities-Life-Science-Summit-EN-26-04-2021.pdf</loc>
<lastmod>2021-04-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-7th-Annual-Truist-Securities-Life-Science-Summit-FR-26-04-2021.pdf</loc>
<lastmod>2021-04-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2021-CA-Cash-EN-12052021-1.pdf</loc>
<lastmod>2021-05-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2021-CA-Cash-FR-12052021-1.pdf</loc>
<lastmod>2021-05-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-Virtual-Healthcare-Conference-EN-25-05-2021.pdf</loc>
<lastmod>2021-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Jefferies-Virtual-Healthcare-Conference-FR-25-05-2021.pdf</loc>
<lastmod>2021-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-Abstract-09-06-2021-.pdf</loc>
<lastmod>2021-06-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-Abstract-09-06-2021.pdf</loc>
<lastmod>2021-06-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-CybeRx-Series-Liver-Disease-Day-FR-14-06-2021.pdf</loc>
<lastmod>2021-06-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-CybeRx-Series-Liver-Disease-Day-EN-14-06-2021.pdf</loc>
<lastmod>2021-06-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2021-CA-Cash-EN-28072021-1.pdf</loc>
<lastmod>2021-07-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2021-CA-Cash-FR-28072021-1.pdf</loc>
<lastmod>2021-07-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ATM-EN-02082021-1.pdf</loc>
<lastmod>2021-08-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ATM-FR-02082021-1.pdf</loc>
<lastmod>2021-08-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-September-events-30-08-2021-.pdf</loc>
<lastmod>2021-08-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-septembre-30-08-2021.pdf</loc>
<lastmod>2021-08-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Initiation-NATiV3-EN-08092021.pdf</loc>
<lastmod>2021-09-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lancement-NATiV3-FR-08092021.pdf</loc>
<lastmod>2021-09-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EN-Webcast-invitation-H1-2021-09-10-2021.pdf</loc>
<lastmod>2021-09-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Recruitments-16-09-2021-1.pdf</loc>
<lastmod>2021-09-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Recrutements-16-09-2021.pdf</loc>
<lastmod>2021-09-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2021-EN-20092021-2.pdf</loc>
<lastmod>2021-09-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2021-FR-20092021-1.pdf</loc>
<lastmod>2021-09-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Fast-Track-EN-21092021.pdf</loc>
<lastmod>2021-09-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Fast-Track-FR-21092021.pdf</loc>
<lastmod>2021-09-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ATM-Activation-EN-23092021.pdf</loc>
<lastmod>2021-09-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ATM-Tirage-FR-23092021.pdf</loc>
<lastmod>2021-09-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-October-events-27-09-2021.pdf</loc>
<lastmod>2021-09-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-octobre-27-09-2021.pdf</loc>
<lastmod>2021-09-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstract-EN-05-18-2021.pdf</loc>
<lastmod>2021-10-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-Abstract-FR-05-18-2021.pdf</loc>
<lastmod>2021-10-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-The-New-England-Journal-of-Medicine-EN-20102021.pdf</loc>
<lastmod>2021-10-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-The-New-England-Journal-of-Medicine-FR-20102021-1.pdf</loc>
<lastmod>2021-10-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Design-lanifibranor-and-SGTL2-EN-28-10-2021-1.pdf</loc>
<lastmod>2021-10-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Design-lanifibranor-and-SGLT2-FR-28-10-2021.pdf</loc>
<lastmod>2021-10-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-November-events-29-10-2021.pdf</loc>
<lastmod>2021-10-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-novembre-29-10-2021.pdf</loc>
<lastmod>2021-10-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-KOL-EN-03-11-2021.pdf</loc>
<lastmod>2021-11-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-KOL-FR-03-11-2021.pdf</loc>
<lastmod>2021-11-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2021-CA-Cash-EN-10112021-1.pdf</loc>
<lastmod>2021-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2021-CA-Cash-FR-10112021-1.pdf</loc>
<lastmod>2021-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-TQT-study-EN-6-12-2021.pdf</loc>
<lastmod>2021-12-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-TQT-study-FR-6-12-2021.pdf</loc>
<lastmod>2021-12-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Annual-J.P.-Morgan-Healthcare-Conference-EN-16-12-2021.pdf</loc>
<lastmod>2021-12-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Annual-J.P.-Morgan-Healthcare-Conference-FR-16-12-2021.pdf</loc>
<lastmod>2021-12-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-January-February-events-20-01-2022.pdf</loc>
<lastmod>2022-01-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-janvier-fevrier-20-01-2022-1.pdf</loc>
<lastmod>2022-01-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cedirogant-milestone-EN-01.31.2022.pdf</loc>
<lastmod>2022-01-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Cedirogant-milestone-FR-01.31.2022.pdf</loc>
<lastmod>2022-01-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/PR-FY-2021-CA-Cash-EN-14022022-1.pdf</loc>
<lastmod>2022-02-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/CP-FY-2021-CA-Cash-FR-14022022-1.pdf</loc>
<lastmod>2022-02-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2021-28-02-2022-EN.pdf</loc>
<lastmod>2022-02-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2021-28-02-2022-FR.pdf</loc>
<lastmod>2022-02-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-March-IR-events-29-02-2022.pdf</loc>
<lastmod>2022-03-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-IR-mars-29-02-2022.pdf</loc>
<lastmod>2022-03-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2021-EN-07-03-2022-2.pdf</loc>
<lastmod>2022-03-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-FY-2021-FR-07-03-2022-2.pdf</loc>
<lastmod>2022-03-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-LEGEND-FDA-decision-EN-08.03.2022.pdf</loc>
<lastmod>2022-03-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-LEGEND-Decision-FDA-FR-08.03.2022.pdf</loc>
<lastmod>2022-03-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-URD-and-20-F-PR-11.03.2022.pdf</loc>
<lastmod>2022-03-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-URD-et-20-F-CP-11.03.2022.pdf</loc>
<lastmod>2022-03-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ICFL-07.03.2022-EN.pdf</loc>
<lastmod>2022-04-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ICFL-07.03.2022-FR-1.pdf</loc>
<lastmod>2022-04-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/03-Inventiva-PR-number-of-shares-and-voting-rigts-as-at-11-April-2022.pdf</loc>
<lastmod>2022-04-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-Availability-of-the-preparatory-documents-EN-1.pdf</loc>
<lastmod>2022-04-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-Mise-a-disposition-des-documents.pdf</loc>
<lastmod>2022-04-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-Press-Release-EIB-Financing-16.05.2022.pdf</loc>
<lastmod>2022-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-Communique-de-presse-Financement-BEI-16.05.2022.pdf</loc>
<lastmod>2022-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2022-CA-Cash-EN-16052022-1-1.pdf</loc>
<lastmod>2022-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2022-CA-Cash-FR-16052022-1.pdf</loc>
<lastmod>2022-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-share-repurchase-program-19.05.2022.pdf</loc>
<lastmod>2022-05-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-programme-de-rachat-dactions-19.05.2022.pdf</loc>
<lastmod>2022-05-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-AG-2022-EN-20.05.2022.pdf</loc>
<lastmod>2022-05-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-2022-FR-20.05.2022.pdf</loc>
<lastmod>2022-05-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Events-May-June-23052022-.pdf</loc>
<lastmod>2022-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenements-mai-juin-23052022.pdf</loc>
<lastmod>2022-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ADA-PR-03062022.pdf</loc>
<lastmod>2022-06-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ADA-FR-03062022.pdf</loc>
<lastmod>2022-06-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Inventiva-joins-the-Euronext-Tech-Leaders-segment-07.06.2022.pdf</loc>
<lastmod>2022-06-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Inventiva-integre-le-segment-Tech-Leaders-dEuronext-07.06.2022.pdf</loc>
<lastmod>2022-06-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-Abstracts-06-09-2022.pdf</loc>
<lastmod>2022-06-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-Abstracts-09-06-2022.pdf</loc>
<lastmod>2022-06-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-KOL-event-EN-16-06-2022.pdf</loc>
<lastmod>2022-06-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-KOL-event-FR-16-06-2022.pdf</loc>
<lastmod>2022-06-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EIB-Warrant-Agreement-07-04-2022.pdf</loc>
<lastmod>2022-07-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EIB-Warrant-Agreement-04-07-2022.pdf</loc>
<lastmod>2022-07-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-LEGEND-Screening-initiation-EN-07-07-2022.pdf</loc>
<lastmod>2022-07-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-LEGEND-Screening-initiation-FR-07-07-2022.pdf</loc>
<lastmod>2022-07-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2022-CA-Cash-EN-28072022-1.pdf</loc>
<lastmod>2022-07-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2022-CA-Cash-FR-28072022-1.pdf</loc>
<lastmod>2022-07-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-H1-2022-07-09-2022-EN-1.pdf</loc>
<lastmod>2022-09-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Webcast-invitation-H1-2022-07-09-2022-FR-1.pdf</loc>
<lastmod>2022-09-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-Sino-Biopharm-Licensing-Agreement-EN-21-09-2022-1.pdf</loc>
<lastmod>2022-09-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-Sino-Biopharm-Licensing-Agreement-FR-21-09-2022.pdf</loc>
<lastmod>2022-09-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2022-EN-22092022-FINAL-2-1.pdf</loc>
<lastmod>2022-09-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2022-FR-21.09.2022-FINAL-1.pdf</loc>
<lastmod>2022-09-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstract-EN-10-21-2022.pdf</loc>
<lastmod>2022-10-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-Abstract-FR-10-21-2022.pdf</loc>
<lastmod>2022-10-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cedirogant-program-EN-10-31-2022.pdf</loc>
<lastmod>2022-10-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-Cedirogant-program-FR-10-31-2022.pdf</loc>
<lastmod>2022-10-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2022-CA-Cash-EN-10112022-EN.pdf</loc>
<lastmod>2022-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2022-CA-Cash-FR-10112022-FR.pdf</loc>
<lastmod>2022-11-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Board-of-Directors-21-11-2022-EN.pdf</loc>
<lastmod>2022-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Board-of-Directors-21-11-2022-FR.pdf</loc>
<lastmod>2022-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-New-patent-US-EN-11-28-2022.pdf</loc>
<lastmod>2022-11-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-New-patent-US-FR-11-28-2022.pdf</loc>
<lastmod>2022-11-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-first-tranche-EIB-EN-12-12-2022.pdf</loc>
<lastmod>2022-12-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-tirage-premiere-tranche-BEI-FR-12-12-2022.pdf</loc>
<lastmod>2022-12-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-Availability-of-the-preparatory-documents-EN-01-03-2023.pdf</loc>
<lastmod>2023-01-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-Mise-a-disposition-des-documents-FR-01-03-2023.pdf</loc>
<lastmod>2023-01-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-number-of-shares-and-voting-rights-as-at-19-December-2022-EN-01-03-2023.pdf</loc>
<lastmod>2023-01-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nombre-total-de-droits-de-vote-et-dactions-au-19-decembre-2022-FR-01-03-2023.pdf</loc>
<lastmod>2023-01-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Changes-clinical-development-of-lanifibranor-EN-01-04-2023.pdf</loc>
<lastmod>2023-01-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Changements-developement-clinique-de-lanifibranor-FR-01-04-2023.pdf</loc>
<lastmod>2023-01-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-AG-2023-EN-26-01-2023.pdf</loc>
<lastmod>2023-01-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-2023-FR-26-01-2023.pdf</loc>
<lastmod>2023-01-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/PR-FY-2022-CA-Cash-EN-14022023-1.pdf</loc>
<lastmod>2023-02-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/CP-FY-2022-CA-Cash-FR-14022023-1.pdf</loc>
<lastmod>2023-02-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-ADA-Abstract-EN-06242023.pdf</loc>
<lastmod>2023-03-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-ADA-Abstract-FR-06242023.pdf</loc>
<lastmod>2023-03-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2022-EN-17.03.2023.pdf</loc>
<lastmod>2023-03-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Webcast-invitation-FY-2022-FR-17.03.2023.pdf</loc>
<lastmod>2023-03-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2022-EN-29.03.2023-1.pdf</loc>
<lastmod>2023-03-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-FY-2022-FR-29.03.2023-1.pdf</loc>
<lastmod>2023-03-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-URD-and-20-F-EN-30032022.pdf</loc>
<lastmod>2023-03-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-URD-and-20-F-FR-30032022.pdf</loc>
<lastmod>2023-03-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-Availability-of-the-preparatory-documents-EN-04-05-2023.pdf</loc>
<lastmod>2023-05-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-Mise-a-disposition-des-documents-FR-04-05-2023.pdf</loc>
<lastmod>2023-05-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-number-of-shares-and-voting-rights-as-of-April-17-2023-EN-04-05-2023.pdf</loc>
<lastmod>2023-05-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nombre-total-de-droits-de-vote-et-dactions-au-17-avril-2023-FR-04-05-2023.pdf</loc>
<lastmod>2023-05-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2023-CA-Cash-EN-16-05-2023-1.pdf</loc>
<lastmod>2023-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2023-CA-Cash-FR-16-05-2023-1.pdf</loc>
<lastmod>2023-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Share-repurchase-program-EN-24-05-2023.pdf</loc>
<lastmod>2023-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Programme-de-rachats-dactions-FR-24-05-2023.pdf</loc>
<lastmod>2023-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-IND-Lanifibranor-China-EN-05-25-2023.pdf</loc>
<lastmod>2023-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-IND-lanifibranor-China-FR-25-05-2023.pdf</loc>
<lastmod>2023-05-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-AG-May-2023-EN-05-26-2023.pdf</loc>
<lastmod>2023-05-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-Mai-2023-FR-26-05-2023.pdf</loc>
<lastmod>2023-05-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-Abstracts-EN-06-07-2023.pdf</loc>
<lastmod>2023-06-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-Abstracts-FR-07-06-2023.pdf</loc>
<lastmod>2023-06-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Inventiva-and-Echosens-Joint-Effort-EN-06-08-2023.pdf</loc>
<lastmod>2023-06-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Inventiva-et-Echosens-Initiative-Conjointe-FR-08-06-2023.pdf</loc>
<lastmod>2023-06-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cusi-Lani-Topline-Results-EN-06132023-1.pdf</loc>
<lastmod>2023-06-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-de-letude-initiee-par-un-investigateur-FR-06132023.pdf</loc>
<lastmod>2023-06-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2023-CA-Cash-EN-07-27-2023-1.pdf</loc>
<lastmod>2023-07-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2023-CA-Cash-FR-27.07.2023-1-1.pdf</loc>
<lastmod>2023-07-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Financing-operation-EN-08-31-2023-1.pdf</loc>
<lastmod>2023-08-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Operation-financiere-FR-31-08-2023-1.pdf</loc>
<lastmod>2023-08-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Japan-Licensing-Agreement-EN-09-20-2023-1.pdf</loc>
<lastmod>2023-09-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Accord-de-licence-Japon-FR-20-09-2023-1.pdf</loc>
<lastmod>2023-09-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2023-EN-09-28-2023-1.pdf</loc>
<lastmod>2023-09-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2023-FR-28-09-2023-1.pdf</loc>
<lastmod>2023-09-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstracts-2023-EN-11062023-2.pdf</loc>
<lastmod>2023-11-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-2023-Abstracts-FR-11062023-2.pdf</loc>
<lastmod>2023-11-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2023-CA-Cash-EN-11-21-2023-1.pdf</loc>
<lastmod>2023-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2023-CA-Cash-FR-21-11-2023-1.pdf</loc>
<lastmod>2023-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-3eme-DMC-NATiV3-FR-12-04-2023.pdf</loc>
<lastmod>2023-12-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-3rd-DMC-NATiV3-EN-12-04-2023.pdf</loc>
<lastmod>2023-12-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-First-patient-randomized-in-China-and-NATiV3-status-update-EN-12-20-2023-2.pdf</loc>
<lastmod>2023-12-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Premier-patient-en-China-et-NATiV3-status-update-FR-20-12-2023-3.pdf</loc>
<lastmod>2023-12-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-BEI-Tranche-B-FR-10-01-2024.pdf</loc>
<lastmod>2024-01-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EIB-Tranche-B-EN-01-10-2024.pdf</loc>
<lastmod>2024-01-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Contrat-de-liquidite-S2-23-FR-24-01-2024.pdf</loc>
<lastmod>2024-01-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Liquidity-contract-H2-23-EN-01-24-2024.pdf</loc>
<lastmod>2024-01-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Full-Year-2023-Revenue-et-Cash-EN-02-15-2024-final-1.pdf</loc>
<lastmod>2024-02-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Full-Year-2023-Revenue-et-Cash-FR-15-02-2024-1-1.pdf</loc>
<lastmod>2024-02-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NATiV3-screening-update-FR-07-03-2024-FINAL.pdf</loc>
<lastmod>2024-03-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATiV3-screening-update-EN-03-07-2024-final.pdf</loc>
<lastmod>2024-03-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-LEGEND-Webcast-announcement-EN-03-13-2024-1.pdf</loc>
<lastmod>2024-03-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-LEGEND-Webcast-annoncement-FR-13-03-2024-1.pdf</loc>
<lastmod>2024-03-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-LEGEND-EN-03-18-2024.pdf</loc>
<lastmod>2024-03-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Results-LEGEND-FR-18-03-2024.pdf</loc>
<lastmod>2024-03-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2023-EN-03-22-2024.pdf</loc>
<lastmod>2024-03-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Webcast-invitation-FY-2023-FR-22.03.2024.pdf</loc>
<lastmod>2024-03-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Full-Year-Results-2023-03-27-2024.pdf</loc>
<lastmod>2024-03-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Full-Year-Results-2023-FR-03272024.pdf</loc>
<lastmod>2024-03-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Nomination-New-Board-Member-EN-03-28-2024.pdf</loc>
<lastmod>2024-03-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nomination-nouveau-Board-Member-FR-03-28-2024.pdf</loc>
<lastmod>2024-03-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-URD-and-20-F-EN-04-03-2024.pdf</loc>
<lastmod>2024-04-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-URD-and-20-F-FR-03-04-2024.pdf</loc>
<lastmod>2024-04-03T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Nature-Communications-Cardiometabolic-paper-EN-05-13-2024.pdf</loc>
<lastmod>2024-05-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nature-Communications-Cardiometabolic-paper-FR-05-13-2024.pdf</loc>
<lastmod>2024-05-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-4th-DMC-NATiV3-EN-05-16-2024.pdf</loc>
<lastmod>2024-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-4eme-DMC-NATiV3-FR-16-05-2024.pdf</loc>
<lastmod>2024-05-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2024-CA-Cash-EN-05-21-2024.pdf</loc>
<lastmod>2024-05-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2024-CA-Cash-FR-21-05-2024.pdf</loc>
<lastmod>2024-05-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-Abstracts-EN-05-22-2024.pdf</loc>
<lastmod>2024-05-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-Abstracts-FR-05-22-2024.pdf</loc>
<lastmod>2024-05-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AGM-Availability-of-the-preparatory-documents-EN-05-30-2024-2.pdf</loc>
<lastmod>2024-05-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Assemblee-generale-Mise-a-disposition-des-documents-FR-05-30-2024-2.pdf</loc>
<lastmod>2024-05-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-of-AG-06-20-2024-EN.pdf</loc>
<lastmod>2024-06-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-20-06-2024-FR-1.pdf</loc>
<lastmod>2024-06-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Share-Repurchase-Program-GM-06-20-2024-EN-06-21-2024.pdf</loc>
<lastmod>2024-06-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Descriptif-du-programme-de-rachat-AG-20-06-2024-FR-21-06-2024.pdf</loc>
<lastmod>2024-06-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-NATiV3-and-fiancial-situation-updates-EN-07-05-2024.pdf</loc>
<lastmod>2024-07-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-NATiV3-et-situation-financiere-updates-FR-07-05-2024.pdf</loc>
<lastmod>2024-07-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Royalty-Deal-EN-07-18-2024.pdf</loc>
<lastmod>2024-07-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/IVA-CP-Royalty-Deal-FR-07-18-2024.pdf</loc>
<lastmod>2024-07-18T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-Cirrhosis-patent-Japan-07-25-2024.pdf</loc>
<lastmod>2024-07-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-Brevet-Japon-FR-07-25-2024-1.pdf</loc>
<lastmod>2024-07-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Preliminary-Financial-information-H1-2024-EN-07-31-2024.pdf</loc>
<lastmod>2024-07-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Informations-financieres-preliminaires-H1-2024-FR-07-31-2024.pdf</loc>
<lastmod>2024-07-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Corporate-and-Financial-updates-EN-09-25-2024-.pdf</loc>
<lastmod>2024-09-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Updates-corporate-et-financiere-FR-09-25-2024_.pdf</loc>
<lastmod>2024-09-25T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Sulphur-FR-10-14-2024-VersionFinale.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Project-Sulphur-EN-10-13-2024-_Version-finale.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-H1-2024-EN-10-14-2024-1-1.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-H1-2024-FR-10-14-2024-1.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Mise-a-disposition-du-Prospectus-FR-10-14-2024.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Prospectus-EN-10-14-2024.pdf</loc>
<lastmod>2024-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstract-2024-EN-10212024-3.pdf</loc>
<lastmod>2024-10-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-2024-Abstract-FR-10-21-2024.pdf</loc>
<lastmod>2024-10-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-5eme-DMC-NATiV3-FR-10-30-2024-1.pdf</loc>
<lastmod>2024-10-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-5th-DMC-NATiV3-EN-10-30-2024-1.pdf</loc>
<lastmod>2024-10-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Lanifibranor-AASLD-Late-Breaker-EN-11-15-2024.pdf</loc>
<lastmod>2024-11-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lanifibranor-AASLD-Late-Breaker-FR-11-15-2024.pdf</loc>
<lastmod>2024-11-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-number-of-shares-and-voting-rights-as-at-04-Nov.-2024-EN-1.pdf</loc>
<lastmod>2024-11-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nombre-total-de-droits-de-vote-et-dactions-au-04-novembre-2024-FR.pdf</loc>
<lastmod>2024-11-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR_AG-December-11-2024-Availability-of-documents-EN-11-20-2024.pdf</loc>
<lastmod>2024-11-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP_AG-December-11-2024-Mise-a-disposition-des-documents-FR-11-20-2024.pdf</loc>
<lastmod>2024-11-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2024-CA-Cash-FR-11-21-2024-Final-1.pdf</loc>
<lastmod>2024-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2024-CA-Cash-EN-11-21-2024-Final.pdf</loc>
<lastmod>2024-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-11-12-2024-FR-12-12-2024.pdf</loc>
<lastmod>2024-12-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-of-GM-11-12-2024-EN-12-12-2024.pdf</loc>
<lastmod>2024-12-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Financement-T1bis-FR-12-16-2024.pdf</loc>
<lastmod>2024-12-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Financing-T1bis-EN-12-16-2024.pdf</loc>
<lastmod>2024-12-16T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Annual-JPM-Healthcare-Conference-EN-12-17-2025.pdf</loc>
<lastmod>2024-12-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Annual-JPM-Healthcare-Conference-FR-12-17-2024.pdf</loc>
<lastmod>2024-12-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-EASL-SLD-Abstract-01-22-2025.pdf</loc>
<lastmod>2025-01-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-SLD-FR-01-22-2025.pdf</loc>
<lastmod>2025-01-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Liquidity-contract-2H24-EN-01242025.pdf</loc>
<lastmod>2025-01-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Contrat-de-liquidite-2H24-FR-01242025.pdf</loc>
<lastmod>2025-01-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Cusi-Journal-of-Hepatology-FR-01-29-2025.pdf</loc>
<lastmod>2025-01-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Cusi-Journal-of-Hepatology-EN-01-29-2025.pdf</loc>
<lastmod>2025-01-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2024-cash-EN-02-10-2025.pdf</loc>
<lastmod>2025-02-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-FY2024-Cash-FR-02-10-2025.pdf</loc>
<lastmod>2025-02-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Phase-1-Hepalys-Pharma-EN-02-20-2025.pdf</loc>
<lastmod>2025-02-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Phase-1-Hepalys-Pharma-FR-02-20-2025.pdf</loc>
<lastmod>2025-02-20T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Biomedicine-Pharma-Publication-FR-02-26-2025.pdf</loc>
<lastmod>2025-02-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Biomedicine-Pharma-Publication-EN-02-26-2025.pdf</loc>
<lastmod>2025-02-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Webcast-invitation-FY-2024-FR-03-19-2025-1.pdf</loc>
<lastmod>2025-03-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Webcast-invitation-FY-2024-EN-03-19-2025-.pdf</loc>
<lastmod>2025-03-19T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Full-Year-results-2024-FR-03-26-2025-1.pdf</loc>
<lastmod>2025-03-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-2024-full-year-results-EN-03-26-2025-1.pdf</loc>
<lastmod>2025-03-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Fin-du-recrutement-NATiV3-FR-04-01-2925-1.pdf</loc>
<lastmod>2025-04-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-End-of-Patient-Randomization-EN-04-01-2025.pdf</loc>
<lastmod>2025-04-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-URD-and-20F-EN-03-15-2025.pdf</loc>
<lastmod>2025-04-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-URD-and-20F-FR-03-15-2025.pdf</loc>
<lastmod>2025-04-15T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Biomarkers-paper-CGH-EN-04-24-2025.pdf</loc>
<lastmod>2025-04-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Biomarkers-paper-CGH-FR-04-24-2025-1.pdf</loc>
<lastmod>2025-04-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-number-of-shares-and-voting-rights-as-at-11-April-2025-EN-04-30-2025.pdf</loc>
<lastmod>2025-04-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nombre-total-de-droits-de-vote-et-dactions-au-11-avril-2025-FR-04-30-2025.pdf</loc>
<lastmod>2025-04-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Availability-of-the-preparatory-documents-of-the-GM-of-May-22-2025-EN-04-30-2025.pdf</loc>
<lastmod>2025-04-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Mise-a-disposition-des-documents-preparatoires-a-lAG-du-22-mai-2025-FR-04-30-2025.pdf</loc>
<lastmod>2025-04-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Seconde-Tranche-Financement-Structure-FR-05-05-2025.pdf</loc>
<lastmod>2025-05-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Second-Tranche-of-Structured-Financing-EN-05-05-2025-1.pdf</loc>
<lastmod>2025-05-05T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Contrat-de-Liquidite-AG-FR-05-22-2025-2.pdf</loc>
<lastmod>2025-05-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Liquidity-agreement-Shareholders-Meeting-EN-05-22-2025-2.pdf</loc>
<lastmod>2025-05-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-Mai-2025-FR-05-23-2025.pdf</loc>
<lastmod>2025-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-General-Meeting-May-2025-EN-05-23-2025-1.pdf</loc>
<lastmod>2025-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q1-2025-FR-05-23-2025-1.pdf</loc>
<lastmod>2025-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q1-2025-EN-05-23-2025-1.pdf</loc>
<lastmod>2025-05-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-June-Investors-Conferences-EN-05-27-2025.pdf</loc>
<lastmod>2025-05-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Participation-conferences-investisseurs-juin-2025-05-27-2025.pdf</loc>
<lastmod>2025-05-27T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Appointment-Renee-Aguiar-Lucanter-to-the-Board-EN-06-10-2025.pdf</loc>
<lastmod>2025-06-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Appoitment-Renee-Aguiar-Lucanter-au-Conseil-dAdministration-FR-06-10-2025.pdf</loc>
<lastmod>2025-06-10T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Journal-of-Hepatology-Reports-FR-07-02-2025.pdf</loc>
<lastmod>2025-07-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Journal-of-Hepatology-Reports-EN-07-02-2025-3.pdf</loc>
<lastmod>2025-07-02T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-CTTQ-milestone-EN-07-07-2025.pdf</loc>
<lastmod>2025-07-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-CTTQ-Milestone-FR-07-07-2025.pdf</loc>
<lastmod>2025-07-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Leadership-Team-Changes-EN-07-09-2025.pdf</loc>
<lastmod>2025-07-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Nominations-Equipe-de-Direction-FR-07-09-2025.pdf</loc>
<lastmod>2025-07-09T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Preliminary-Financial-Information-H1-2025-EN-07-29-2025.pdf</loc>
<lastmod>2025-07-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Informations-financieres-preliminaires-H1-2024-FR-07-29-2025-FINAL.pdf</loc>
<lastmod>2025-07-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-liquidity-contract-H1-2025-ENG-07-31-2025.pdf</loc>
<lastmod>2025-07-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-contrat-de-liquidite-S1-2025-FR-07-31-2025.pdf</loc>
<lastmod>2025-07-31T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Canaccord-Participation-EN-08-11-2025.pdf</loc>
<lastmod>2025-08-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Participation-Canaccord-Conference-FR-08-11-2025.pdf</loc>
<lastmod>2025-08-11T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Investors-Conferences-September-EN-09-04-2025.pdf</loc>
<lastmod>2025-09-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Participation-Conferences-Investisseurs-Septembre-FR-09-04-2025.pdf</loc>
<lastmod>2025-09-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Analyst-and-Investor-Day-October-8-EN-09-24-2025-1.pdf</loc>
<lastmod>2025-09-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Evenement-Analyst-et-Investisseur-8-octobre-FR-09-24-2025.pdf</loc>
<lastmod>2025-09-24T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-1H2025-Financial-Report-EN-09-29-2025-1.pdf</loc>
<lastmod>2025-09-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-1H2025-Resultats-Financiers-FR-09-29-2025-1-1.pdf</loc>
<lastmod>2025-09-29T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Inventiva-annonces-new-CEO-Andrew-Obenshain-EN-10-01-2025.pdf</loc>
<lastmod>2025-10-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Inventiva-annonce-new-CEO-Andrew-Obenshain-FR-10-01-2025.pdf</loc>
<lastmod>2025-10-01T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-AASLD-Abstracts-2025-FR-07-10-2025.pdf</loc>
<lastmod>2025-10-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-AASLD-Abstracts-2025-EN-10-07-2025-1.pdf</loc>
<lastmod>2025-10-07T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-At-The-Market-Program-EN-10-14-2025.pdf</loc>
<lastmod>2025-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-At-The-Market-Program-FR-10-14-2025.pdf</loc>
<lastmod>2025-10-14T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Availability-of-the-preparatory-documents-of-the-GM-of-November-27-2025-EN-11-06-2025.pdf</loc>
<lastmod>2025-11-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Mise-a-disposition-des-documents-preparatoires-a-lAG-du-27-novembre-2025-FR-11-06-2025.pdf</loc>
<lastmod>2025-11-06T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Launch-Public-Offering-EN-11-12-2025.pdf</loc>
<lastmod>2025-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Lancement-Offre-au-Public-FR-11-12-2025.pdf</loc>
<lastmod>2025-11-12T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Trading-Halt-EN-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Suspension-de-cours-FR-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Pricing-Public-Offering-EN-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-modalites-definitives-ainsi-que-lextension-de-loffre-au-public-FR-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Resumption-of-Trading-Press-Release-EN-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-reprise-des-negociations-de-ses-actions-ordinaires-sur-Euronext-FR-11-13-2025.pdf</loc>
<lastmod>2025-11-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Full-Execution-of-Public-Offering-EN-11-17-2025.pdf</loc>
<lastmod>2025-11-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Exercice-integral-de-lOption-des-Banques-FR-11-17-2025.pdf</loc>
<lastmod>2025-11-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Q3-2025-CA-Cash-EN-11-21-2025.pdf</loc>
<lastmod>2025-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Q3-2025-CA-Cash-FR-11-21-2025-2.pdf</loc>
<lastmod>2025-11-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Resultats-AG-Novembre-2025-FR-11-28-2025.pdf</loc>
<lastmod>2025-11-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Results-General-Meeting-November-2025-EN-11-28-2025-1.pdf</loc>
<lastmod>2025-11-28T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-JPM-2026-FR-12-17-2025-2.pdf</loc>
<lastmod>2025-12-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-JPM-2026-EN-12-17-2025.pdf</loc>
<lastmod>2025-12-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Liquidity-contract-H2-2025-01-21-2026.pdf</loc>
<lastmod>2026-01-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Contrat-de-liquidite-S2-2025-01-26-2026.pdf</loc>
<lastmod>2026-01-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-Guggenheim-Feb-2026-EN-02-05-2026.pdf</loc>
<lastmod>2026-02-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-Guggenheim-Fevrier-2026-02-05-2026.pdf</loc>
<lastmod>2026-02-04T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Preliminary-FY25-FR-02-17-2026.pdf</loc>
<lastmod>2026-02-17T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Investor-Conferences-March-EN-02-25-2026-2.pdf</loc>
<lastmod>2026-02-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Conferences-Investisseur-Mars-FR-02-26-2026-1.pdf</loc>
<lastmod>2026-02-26T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-FY-2025-Results-Webcast-EN-03-23-2026.pdf</loc>
<lastmod>2026-03-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-FY-2025-Resultats-Webcast-FR-03-23-2026.pdf</loc>
<lastmod>2026-03-23T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Full-Year-results-2025-FR-03-30-2026-1-1.pdf</loc>
<lastmod>2026-03-30T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-URD-and-20F-FR-04-08-2026.pdf</loc>
<lastmod>2026-04-08T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Leadership-Team-Members-FR-04-22-2026.pdf</loc>
<lastmod>2026-04-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Leadership-Team-Members-EN-04-22-2026.pdf</loc>
<lastmod>2026-04-22T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Abstracts-EASL-2026-EN-05-13-2026.pdf</loc>
<lastmod>2026-05-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-EASL-Abstracts-2026-FR-05-13-2026.pdf</loc>
<lastmod>2026-05-13T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Jefferies-2026-EN-05-21-2026-irYVHf.pdf</loc>
<lastmod>2026-05-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/inventiva-documents/Inventiva-CP-Jefferies-2026-EN-05-21-2026-VK6o9n.pdf</loc>
<lastmod>2026-05-21T12:00:00+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Q1-2026-Financial-Report-EN-05-26-2026.pdf</loc>
<lastmod>2026-05-26T13:20:51+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Q1-2026-FR-05-26-2026b-1.pdf</loc>
<lastmod>2026-05-26T13:21:10+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Pause-Trade-FR-06-02-2026.pdf</loc>
<lastmod>2026-06-01T22:41:38+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Trading-Halt-EN-06-02-2026-1.pdf</loc>
<lastmod>2026-06-01T22:41:50+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-URD-and-20F-EN-04-08-2026.pdf</loc>
<lastmod>2026-06-01T22:52:47+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Full-Year-results-2025-EN-03-30-2026-1.pdf</loc>
<lastmod>2026-06-01T22:53:27+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/inventiva-documents/Inventiva-PR-Preliminary-FY-2025-EN-02-17-2026.pdf</loc>
<lastmod>2026-06-01T22:54:02+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Debt-and-Equity-EN-06-02-2026.pdf</loc>
<lastmod>2026-06-02T05:40:44+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Debt-and-Equity-FR-06-02-2026.pdf</loc>
<lastmod>2026-06-02T05:41:16+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Reprise-Trading-FR-06-02-2026-1.pdf</loc>
<lastmod>2026-06-02T05:43:39+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Resumption-Trading-EN-06-02-2026.pdf</loc>
<lastmod>2026-06-02T08:45:39+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-GeneralMeeting-EN-06-09-2026.pdf</loc>
<lastmod>2026-06-09T14:39:25+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-AG-FR-06-09-2026.pdf</loc>
<lastmod>2026-06-09T14:41:13+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Voting-Rights-EN-06-09-2026.pdf</loc>
<lastmod>2026-06-09T14:49:43+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Nombre-de-Droit-de-Votes-FR-06-09-2026.pdf</loc>
<lastmod>2026-06-09T14:50:45+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Transactions-Closing-FR-06-12-2026.pdf</loc>
<lastmod>2026-06-12T13:54:59+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Transactions-Closing-EN-06-12-2026.pdf</loc>
<lastmod>2026-06-12T16:45:24+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-EN-Results-of-the-votes-of-the-shareholder-meeting-PR-06-30-2026.pdf</loc>
<lastmod>2026-07-02T06:43:36+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-FR-Resultats-des-votes-AGM-CP-06-30-2026.pdf</loc>
<lastmod>2026-07-02T06:44:10+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-New-Board-Members-EN-07-08-2026.pdf</loc>
<lastmod>2026-07-08T14:37:05+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Nouveaux-Admintrateurs-Conseil-dadministration-FR-07-08-2026.pdf</loc>
<lastmod>2026-07-08T14:38:50+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-EIB-Warrants-Issuance-EN-07-09-2026.pdf</loc>
<lastmod>2026-07-09T16:19:24+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Emission-BSA-EIB-FR-07-09-2026.pdf</loc>
<lastmod>2026-07-09T16:19:31+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Resultats-Financiers-Preliminaires-H1-2026-FR-07-30-2026.pdf</loc>
<lastmod>2026-07-30T15:31:18+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Preliminary-Financial-Results-H1-2026-EN-07-30-2026.pdf</loc>
<lastmod>2026-07-30T15:32:04+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-COO-Chris-Benecchi-EN-08-31-2026-1.pdf</loc>
<lastmod>2026-08-31T13:50:10+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Inventiva-COO-Chris-Benecchi-FR-08-31-2026-1.pdf</loc>
<lastmod>2026-08-31T13:51:21+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-Inventiva-LVLP-EN-09-02-2026.pdf</loc>
<lastmod>2026-09-02T16:22:37+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Inventiva-LVLP-FR-09-02-2026-2.pdf</loc>
<lastmod>2026-09-02T16:23:11+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-Paris-MASH-Abstracts-FR-09-08-2026.pdf</loc>
<lastmod>2026-09-08T16:03:45+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/INVENTIVA-Paris-MASH-Poster-Presentations-EN-9.8.26.pdf</loc>
<lastmod>2026-09-08T16:03:56+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/Inventiva-PR-H1-2026-Financial-Results-EN-09-28-2026.pdf</loc>
<lastmod>2026-09-27T15:56:58+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/Inventiva-CP-H1-2026-Resultats-Financiers-FR-09-28-2026-1.pdf</loc>
<lastmod>2026-09-27T16:00:28+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/wp-content/uploads/INVENTIVA-AALSD-Abstracts-PR-EN-10.6.2026-1.pdf</loc>
<lastmod>2026-10-06T16:11:23+00:00</lastmod>
</url>			<url>
<loc>https://inventivapharma.com/fr/wp-content/uploads/INVENTIVA-CP-Abstracts-AASLD-2026-FR-10-06-2026-1.pdf</loc>
<lastmod>2026-10-06T16:12:32+00:00</lastmod>
</url>	</urlset>
<link rel='stylesheet' href='https://inventivapharma.com/wp-content/plugins/magnetiks-consent/public/css/magconsent.css?ver=1.2.5' />
<script>window.MagConsentData={"cookieName":"magnetiks_consent","expiryDays":180,"regime":"optin","gpcRespect":1,"gpcSignal":0,"reloadOnAccept":1,"categories":["necessary","functional","statistics","marketing"],"restUrl":"https:\/\/inventivapharma.com\/wp-json\/magconsent\/v1\/log","ajaxUrl":"https:\/\/inventivapharma.com\/wp-admin\/admin-ajax.php","nonce":"8bc62b1c5d","lang":"en","policyVersion":"1","preview":0};</script>
<div id="magconsent-root"
	class="magconsent magconsent--light magconsent--bottom magconsent--optin"
	data-regime="optin"
	style="--magconsent-accent: #e3402c; --magconsent-accent-accept: #1a7f43;"
	role="dialog" aria-modal="false" aria-live="polite"
	aria-label="Cookie preferences" hidden>

	<div class="magconsent__overlay" data-magconsent-overlay></div>

	<!-- Bannière initiale -->
	<div class="magconsent__banner" data-magconsent-view="banner">
		<div class="magconsent__body">
			<h2 class="magconsent__title">We value your privacy</h2>
			<p class="magconsent__text">
				We use cookies to improve your browsing experience, analyse traffic and, with your consent, personalise content. You can accept, reject or customise your choices.							</p>
		</div>
		<div class="magconsent__actions">
							<button type="button" class="magconsent__btn magconsent__btn--ghost" data-magconsent-action="customize">Customise</button>
										<button type="button" class="magconsent__btn magconsent__btn--ghost" data-magconsent-action="reject">Reject all</button>
						<button type="button" class="magconsent__btn magconsent__btn--primary" data-magconsent-action="accept">Accept all</button>
		</div>
			</div>

	<!-- Panneau de préférences -->
	<div class="magconsent__panel" data-magconsent-view="panel" hidden>
		<div class="magconsent__panel-head">
			<h2 class="magconsent__title">Cookie preferences</h2>
			<button type="button" class="magconsent__close" data-magconsent-action="close" aria-label="Close">&times;</button>
		</div>
		<p class="magconsent__text">Enable or disable cookie categories. Strictly necessary cookies are always active.</p>

		<div class="magconsent__cats">
											<div class="magconsent__cat">
					<div class="magconsent__cat-head">
						<span class="magconsent__cat-name">Strictly necessary</span>
						<label class="magconsent__switch">
							<input type="checkbox"
								data-magconsent-cat="necessary"
								checked disabled />
							<span class="magconsent__slider"></span>
															<span class="magconsent__always">Always on</span>
													</label>
					</div>
					<p class="magconsent__cat-desc">Essential for the website to function (navigation, security, session). They cannot be disabled.</p>
				</div>
											<div class="magconsent__cat">
					<div class="magconsent__cat-head">
						<span class="magconsent__cat-name">Functional</span>
						<label class="magconsent__switch">
							<input type="checkbox"
								data-magconsent-cat="functional"
								 />
							<span class="magconsent__slider"></span>
													</label>
					</div>
					<p class="magconsent__cat-desc">Improve usability: remembering language, region and your preferences.</p>
				</div>
											<div class="magconsent__cat">
					<div class="magconsent__cat-head">
						<span class="magconsent__cat-name">Statistics</span>
						<label class="magconsent__switch">
							<input type="checkbox"
								data-magconsent-cat="statistics"
								 />
							<span class="magconsent__slider"></span>
													</label>
					</div>
					<p class="magconsent__cat-desc">Help us understand how the site is used (page views, audience) to optimise it.</p>
				</div>
											<div class="magconsent__cat">
					<div class="magconsent__cat-head">
						<span class="magconsent__cat-name">Marketing</span>
						<label class="magconsent__switch">
							<input type="checkbox"
								data-magconsent-cat="marketing"
								 />
							<span class="magconsent__slider"></span>
													</label>
					</div>
					<p class="magconsent__cat-desc">Allow relevant advertising to be shown and campaigns to be measured.</p>
				</div>
					</div>

		<div class="magconsent__actions">
			<button type="button" class="magconsent__btn magconsent__btn--ghost" data-magconsent-action="reject">Reject all</button>
			<button type="button" class="magconsent__btn magconsent__btn--ghost" data-magconsent-action="save">Save my choices</button>
			<button type="button" class="magconsent__btn magconsent__btn--primary" data-magconsent-action="accept">Accept all</button>
		</div>

			</div>
</div>

<!-- Onglet « Gérer le consentement » -->
<button type="button" id="magconsent-tab" class="magconsent-tab magconsent-tab--light" style="--magconsent-accent: #e3402c;" data-magconsent-action="reopen" hidden>
	<span class="magconsent-tab__icon" aria-hidden="true">&#127850;</span>
	<span class="magconsent-tab__label">Manage consent</span>
</button>

		<script src='https://inventivapharma.com/wp-content/plugins/magnetiks-consent/public/js/magconsent.js?ver=1.2.5'></script>
